The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Regulatory News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.50
Bid: 48.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 1.00 (2.083%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 48.50
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

18 Aug 2016 10:27

RNS Number : 5491H
Cambridge Cognition Holdings PLC
18 August 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Cambridge Cognition Holdings PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

NIGEL WRAY

4. Full name of shareholder(s)  (if different from 3.):iv

PERSHING NOMINEES LIMITED

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

17 August 2016

6. Date on which issuer notified:

18 August 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

21.11%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORDINARY SHARES

GB00B8DV9647

3,435,714

3,435,714

 

4,312,714

4,312,714

21.11%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,312,714

Figures are based on total number of voting rights 20,429,235

21.11%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Nigel Wray has a beneficial interest in 4,312,714 ordinary shares in Cambridge Cognition Holdings PLC held by Pershing Nominees Limited

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

The percentage increase is based on an accumulation of purchases over a period of time.

 

14. Contact name:

Nigel Wray

15. Contact telephone number:

020 7647 7647

 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Nigel Wray

Contact address

(registered office for legal entities)

 

Cavendish House, 18 Cavendish Square,

London W1G 0PJ

Phone number & email

 

020 7647 7467

Nigel.wray@brendonstreet.com

Other useful information

(at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable

Full name

 

Contact address

 

Phone number & email

 

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPPMLTMBTBMIF
Date   Source Headline
8th Apr 20214:40 pmRNSSecond Price Monitoring Extn
8th Apr 20214:36 pmRNSPrice Monitoring Extension
8th Apr 20212:06 pmRNSSecond Price Monitoring Extn
8th Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 202111:05 amRNSSecond Price Monitoring Extn
8th Apr 202111:00 amRNSPrice Monitoring Extension
8th Apr 20217:00 amRNSNew £0.5m contract for cognitive at home testing
30th Mar 20217:00 amRNS£1.3 million contract for a schizophrenia trial
23rd Mar 20217:00 amRNSResults for the year ended 31 December 2020
11th Mar 20217:00 amRNSInvestor Presentation
17th Feb 20216:20 pmRNSHolding(s) in Company
19th Jan 20216:03 pmRNSHolding(s) in Company
19th Jan 202111:06 amRNSSecond Price Monitoring Extn
19th Jan 202111:00 amRNSPrice Monitoring Extension
19th Jan 20217:00 amRNSTrading Update, Board Change & Notice of Results
21st Dec 20207:00 amRNSNew digital health contract worth over £700,000
2nd Dec 20201:10 pmRNSHolding(s) in Company
2nd Nov 20202:55 pmRNSGrant of Options
7th Oct 20207:00 amRNSNew £750,000 digital health contract
5th Oct 20207:00 amRNSInvestor Presentation
22nd Sep 20207:00 amRNSInterim Results
21st Sep 20203:13 pmRNSHolding(s) in Company
14th Sep 20207:00 amRNSAppointment of Non-Executive Director
8th Sep 20209:57 amRNSNotice of Results
7th Sep 202012:19 pmRNSHolding(s) in Company
1st Sep 20207:00 amRNS£2m contract for three schizophrenia trials
27th Jul 20201:11 pmRNSResult of AGM and Board Changes
15th Jul 20207:00 amRNSNew virtual study with COVID-19 healthcare workers
3rd Jul 20203:30 pmRNSPosting of Annual Report & Notice of AGM
30th Jun 20209:00 amRNSAnnual Report & Notice of AGM
30th Jun 20207:00 amRNSTrading Update
23rd Jun 20204:18 pmRNSHolding(s) in Company
9th Jun 20207:00 amRNSGrant of Options
5th Jun 20207:00 amRNSCapital Markets Showcase
27th May 20207:00 amRNSOver £1 million of New Contract Wins
6th May 20206:11 pmRNSHolding(s) in Company
6th May 202012:15 pmRNSHolding(s) in Company
5th May 20207:00 amRNSPreliminary Results - Year ended 31 December 2019
29th Apr 20202:19 pmRNSNotice of Results
14th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
23rd Mar 20204:00 pmRNSDelayed Preliminary Results
19th Mar 20207:00 amRNSAward of Innovative Medicines Initiative grant
17th Mar 20207:00 amRNS£1.37 million of new eCOA contracts
10th Mar 20204:15 pmRNSHolding(s) in Company
10th Mar 20204:15 pmRNSHolding(s) in Company
9th Mar 202012:46 pmRNSResult of General Meeting
19th Feb 20207:01 amRNSFundraising to raise £1.4m & Notice of GM
19th Feb 20207:00 amRNSTrading Update and Notice of Results
10th Jan 20203:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.